LCTX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Lineage Cell Therapeutics Inc

NYSE MKT | LCTX

1.70

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$413.33M

Market Cap

-

P/E Ratio

-0.17

EPS

$1.85

52 Week High

$0.36

52 Week Low

HEALTHCARE

Sector

LCTX Chart

Recent Chart
Price Action

LCTX Technicals

Tags:

LCTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $9.2M
Total Revenue $9.5M
Cost Of Revenue $334K
Costof Goods And Services Sold $334K
Operating Income -$21M
Selling General And Administrative $18M
Research And Development $12M
Operating Expenses $31M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $1.7M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $609K
Income Before Tax -$19M
Income Tax Expense $27K
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda -$21M
Net Income -$19M

Revenue & Profitability

Earnings Performance

LCTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $113M
Total Current Assets $51M
Cash And Cash Equivalents At Carrying Value $46M
Cash And Short Term Investments $46M
Inventory -
Current Net Receivables $638K
Total Non Current Assets $62M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $47M
Intangible Assets Excluding Goodwill $47M
Goodwill $11M
Investments -
Long Term Investments -
Short Term Investments $2M
Other Current Assets $2.6M
Other Non Current Assets -
Total Liabilities $36M
Total Current Liabilities $14M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $22M
Capital Lease Obligations $2.5M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.5M
Other Current Liabilities $4.3M
Other Non Current Liabilities -
Total Shareholder Equity $78M
Treasury Stock -
Retained Earnings -$403M
Common Stock $485M
Common Stock Shares Outstanding $200M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$23M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $609K
Capital Expenditures $565K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$2.3M
Cashflow From Financing $36M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$23K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $9.2M
Total Revenue $9.5M
Cost Of Revenue $334K
Costof Goods And Services Sold $334K
Operating Income -$21M
Selling General And Administrative $18M
Research And Development $12M
Operating Expenses $31M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $1.7M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $609K
Income Before Tax -$19M
Income Tax Expense $27K
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda -$21M
Net Income -$19M

Dividends

Field Value
Ex Dividend Date 2016-01-04
Declaration Date None
Record Date None
Payment Date None
Amount 0.3125

LCTX Profile

Lineage Cell Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lineage Cell Therapeutics, Inc. is a forward-looking clinical-stage biotechnology firm based in Carlsbad, California, specializing in the development and commercialization of innovative cell-based therapies for degenerative diseases. With a strong emphasis on regenerative medicine, the company harnesses proprietary technologies to address significant unmet medical needs globally. Lineage boasts a robust and diverse pipeline supported by strategic collaborations, positioning it for substantial growth as it advances its clinical candidates. This unique focus on regenerative therapeutics makes Lineage an attractive investment opportunity for institutional investors seeking to capitalize on advancements in the biotech sector.

VHAI
-20.00%
$0.00
VIVK
-3.01%
$0.28
YYAI
-10.71%
$0.12
BURU
+2.88%
$0.34
NVDA
-0.11%
$179.83
RXRX
-7.21%
$6.29
EPWK
+16.29%
$0.08
CGBS
-39.47%
$0.03
BITF
-15.68%
$5.45
ADAP
+6.57%
$0.19
PLUG
-7.01%
$3.58
YDKG
-54.14%
$0.08
IVF
+129.44%
$1.73
NVTS
+2.73%
$15.57
BYND
-22.39%
$0.52
DNN
-2.83%
$3.08
RGTI
-12.76%
$49.15
NIO
-1.09%
$6.74
MIRA
+49.24%
$1.97
SCNX
+0.26%
$0.71
BBD
+1.71%
$3.25
WHWK
+27.64%
$2.68
F
-0.63%
$11.68
ACHR
-7.36%
$12.07
TLRY
-8.41%
$1.53
TSLA
+1.37%
$435.15
IONZ
+18.46%
$3.41
KVUE
-12.91%
$14.16
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
DFLI
-32.52%
$1.32
CAN
-14.28%
$1.68
HPE
-10.09%
$22.51
ONDS
-15.03%
$8.07
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
ETHD
+4.23%
$3.94
RIG
-3.00%
$3.21
MARA
-11.62%
$20.18
CLF
-3.39%
$13.47
BTG
+3.96%
$5.89
LAES
-15.15%
$6.35
AAL
-6.00%
$11.75
VSEE
-8.84%
$0.54
GNPX
-47.58%
$0.44
ABAT
-21.00%
$8.94
LGCB
+35.15%
$2.23
QBTS
-10.47%
$40.08
BTBT
-8.82%
$3.70
QS
-12.89%
$15.54
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
NAK
-16.47%
$2.20
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
MASK
+18.73%
$0.57
CRML
-13.51%
$19.64
IREN
-8.94%
$61.89
SNAP
-2.46%
$7.71
RR
-6.38%
$5.76
CIFR
-10.08%
$18.91
CLSK
-13.92%
$19.97
FEMY
+31.43%
$0.72
RMBL
+60.50%
$3.21
GPUS
-6.53%
$0.36
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
SOUN
-3.66%
$20.61
WOK
+1.03%
$0.05
AUUD
+3.41%
$2.12
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SOND
+78.80%
$1.64
PLTR
-0.81%
$178.16
WTO
-88.69%
$0.13
SMR
-7.73%
$49.29
TOVX
-47.86%
$0.43
FNB
-8.00%
$14.52
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
JBLU
-4.94%
$4.70
AMZN
-0.81%
$213.82
HIMS
-6.07%
$58.94
NOK
+0.44%
$5.67
HBAN
-4.62%
$15.46
WULF
-8.82%
$14.10
SATL
-27.65%
$2.99
AMC
-1.77%
$2.77
ELWS
+48.09%
$5.45
GGB
-0.46%
$3.24
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
PFE
-0.12%
$24.35
KEY
-6.45%
$16.58
AG
+2.27%
$15.20
VHAI
-20.00%
$0.00
VIVK
-3.01%
$0.28
YYAI
-10.71%
$0.12
BURU
+2.88%
$0.34
NVDA
-0.11%
$179.83
RXRX
-7.21%
$6.29
EPWK
+16.29%
$0.08
CGBS
-39.47%
$0.03
BITF
-15.68%
$5.45
ADAP
+6.57%
$0.19
PLUG
-7.01%
$3.58
YDKG
-54.14%
$0.08
IVF
+129.44%
$1.73
NVTS
+2.73%
$15.57
BYND
-22.39%
$0.52
DNN
-2.83%
$3.08
RGTI
-12.76%
$49.15
NIO
-1.09%
$6.74
MIRA
+49.24%
$1.97
SCNX
+0.26%
$0.71
BBD
+1.71%
$3.25
WHWK
+27.64%
$2.68
F
-0.63%
$11.68
ACHR
-7.36%
$12.07
TLRY
-8.41%
$1.53
TSLA
+1.37%
$435.15
IONZ
+18.46%
$3.41
KVUE
-12.91%
$14.16
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
DFLI
-32.52%
$1.32
CAN
-14.28%
$1.68
HPE
-10.09%
$22.51
ONDS
-15.03%
$8.07
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
ETHD
+4.23%
$3.94
RIG
-3.00%
$3.21
MARA
-11.62%
$20.18
CLF
-3.39%
$13.47
BTG
+3.96%
$5.89
LAES
-15.15%
$6.35
AAL
-6.00%
$11.75
VSEE
-8.84%
$0.54
GNPX
-47.58%
$0.44
ABAT
-21.00%
$8.94
LGCB
+35.15%
$2.23
QBTS
-10.47%
$40.08
BTBT
-8.82%
$3.70
QS
-12.89%
$15.54
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
NAK
-16.47%
$2.20
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
MASK
+18.73%
$0.57
CRML
-13.51%
$19.64
IREN
-8.94%
$61.89
SNAP
-2.46%
$7.71
RR
-6.38%
$5.76
CIFR
-10.08%
$18.91
CLSK
-13.92%
$19.97
FEMY
+31.43%
$0.72
RMBL
+60.50%
$3.21
GPUS
-6.53%
$0.36
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
SOUN
-3.66%
$20.61
WOK
+1.03%
$0.05
AUUD
+3.41%
$2.12
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SOND
+78.80%
$1.64
PLTR
-0.81%
$178.16
WTO
-88.69%
$0.13
SMR
-7.73%
$49.29
TOVX
-47.86%
$0.43
FNB
-8.00%
$14.52
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
JBLU
-4.94%
$4.70
AMZN
-0.81%
$213.82
HIMS
-6.07%
$58.94
NOK
+0.44%
$5.67
HBAN
-4.62%
$15.46
WULF
-8.82%
$14.10
SATL
-27.65%
$2.99
AMC
-1.77%
$2.77
ELWS
+48.09%
$5.45
GGB
-0.46%
$3.24
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
PFE
-0.12%
$24.35
KEY
-6.45%
$16.58
AG
+2.27%
$15.20
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.